Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

Back to Item »

Promising Data for Type 1 and 2 Diabetes Candidates Presented at ADA Meeting

Novo Nordisk, BI, Lilly, BMS, and AstraZeneca are among firms providing update on pivotal studies.

Forward this item to a colleague:


 
   

(Separate multiple addresses by commas)

   

(Separate multiple addresses by commas)

Be sure to take the GEN Poll

CRISPR Patent Controversy

Do you think recently released email from a former Broad Institute scientist to Jennifer Doudna will expedite a final legal decision on who owns the CRISPR patent?

More »